Arvind Negi
Title
Cited by
Cited by
Year
Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents
G Joshi, PK Singh, A Negi, A Rana, S Singh, R Kumar
Chemico-biological interactions 240, 120-133, 2015
502015
Synthesis and xanthine oxidase inhibitory activity of 5, 6-dihydropyrazolo/pyrazolo [1, 5-c] quinazoline derivatives
D Kumar, G Kaur, A Negi, S Kumar, S Singh, R Kumar
Bioorganic chemistry 57, 57-64, 2014
392014
Imine/amide–imidazole conjugates derived from 5-amino-4-cyano-N1-substituted benzyl imidazole: Microwave-assisted synthesis and anticancer activity via …
A Negi, JM Alex, SM Amrutkar, AT Baviskar, G Joshi, S Singh, ...
Bioorganic & medicinal chemistry 23 (17), 5654-5661, 2015
342015
Recent advancements in small molecule inhibitors of insulin–like growth factor-1 receptor (IGF-1R) tyrosine kinase as anticancer agents
A Negi, P Ramarao, R Kumar
Mini reviews in medicinal chemistry 13 (5), 653-681, 2013
312013
Design, microwave-mediated synthesis and biological evaluation of novel 4-aryl (alkyl) amino-3-nitroquinoline and 2, 4-diaryl (dialkyl) amino-3-nitroquinolines as anticancer agents
M Chauhan, A Rana, JM Alex, A Negi, S Singh, R Kumar
Bioorganic chemistry 58, 1-10, 2015
252015
Toxicophore exploration as a screening technology for drug design and discovery: techniques, scope and limitations
PK Singh, A Negi, PK Gupta, M Chauhan, R Kumar
Archives of toxicology 90 (8), 1785-1802, 2016
192016
Decorated macrocycles via ring-closing double-reductive amination. Identification of an apoptosis inducer of leukemic cells that at least partially antagonizes a 5-HT2 receptor
J Zhou, M Reidy, C O’Reilly, DV Jarikote, A Negi, A Samali, E Szegezdi, ...
Organic letters 17 (7), 1672-1675, 2015
172015
Success stories of enolate form of drugs
A Negi, BS Gill
PharmaTutor 1 (2), 45-53, 2013
152013
Indole based alkaloid in cancer: an overview
A Negi, R Singla, V Singh
PharmaTutor 2 (1), 76-82, 2014
132014
Development of Mcl-1 inhibitors for cancer therapy
A Negi, PV Murphy
European Journal of Medicinal Chemistry, 113038, 2020
92020
Inverse docking based screening and identification of protein targets for Cassiarin alkaloids against Plasmodium falciparum
A Negi, N Bhandari, BRK Shyamlal, S Chaudhary
Saudi pharmaceutical journal 26 (4), 546-567, 2018
92018
Tilling: versatile reverse genetic tool
A Negi, BS Gill, N Navgeet, SS Anand
PharmaTutor 2 (1), 26-32, 2014
92014
Cystathionine β-lyase-like protein with pyridoxal binding domain characterized in leishmania major by comparative sequence analysis and homology modelling
A Negi, S Bhushan, P Gupta, P Garg, R Kumar
International Scholarly Research Notices 2013, 2013
52013
N-Alkyl-1, 5-dideoxy-1, 5-imino-L-fucitols as fucosidase inhibitors: Synthesis, molecular modelling and activity against cancer cell lines
J Zhou, A Negi, SI Mirallai, R Warta, C Herold-Mende, MP Carty, XS Ye, ...
Bioorganic chemistry 84, 418-433, 2019
42019
Ligand design for somatostatin receptor isoforms 4 and 5
A Negi, J Zhou, S Sweeney, PV Murphy
European journal of medicinal chemistry 163, 148-159, 2019
42019
Synthetic indole alkaloids in cancer: an overview
R Singla, V Singh, A Negi
Adv J Pharm Life sci Res 1 (1), 7-15, 2013
42013
Anaphylactic shock: shocking error of immune system!
A Negi
PharmaTutor 1 (2), 12-16, 2013
32013
Impact of protein tyrosine phosphate on cancer metastasis: an overview
A Negi, AK Pandey, G Joshi, V Agnihotri
World J Pharm Res Technol 1 (2), 118-130, 2013
32013
Multi-targeting protein-protein interaction inhibitors: Evolution of macrocyclic ligands with embedded carbohydrates (MECs) to improve selectivity
A Negi, CO Reilly, DV Jarikote, J Zhou, PV Murphy
European journal of medicinal chemistry 176, 292-309, 2019
22019
Selectivity Control in the Oxidative Ring-Opening of Dimethylfuran Mediated by Zeolitic-Imidazolate Framework-8 Nanoparticles
A Franco, A Negi, R Luque, C Carrillo-Carrión
ACS Sustainable Chemistry & Engineering, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–20